News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
PathogenDx Launches Novel D3 Array Multiplexed Molecular Diagnostics Technology for Urinary Tract Infection (UTI) Pathogen Detection and Antibiotic Resistance
February 7, 2024
·
2 min read
Biotech Beach
Skye Bioscience to Present at Oppenheimer Investor Conference
February 7, 2024
·
3 min read
Drug Development
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences
February 6, 2024
·
7 min read
Therma Bright’s Venowave Accepted for Review By Center for Medicare & Medicaid Services for Permanent CPT and HCPCS codes
February 6, 2024
·
3 min read
PurMinds NeuroPharma Selected to Present at the 2024 OBIO Investment Summit
February 6, 2024
·
4 min read
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
February 6, 2024
·
7 min read
Awakn Life Sciences Announces Conditional Approval of CSE Listing
February 5, 2024
·
5 min read
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement
February 1, 2024
·
5 min read
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
February 1, 2024
·
7 min read
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases
February 1, 2024
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us